Cite
MLA Citation
W. Scheithauer et al.. “2089 Response to chemotherapy allows to identify mCRC patients most likely to benefit from maintenance immunotherapy: A post-hoc analysis from the IMPACT study.” European journal of cancer, vol. 51, n.d., pp. S357–S358. http://access.bl.uk/ark:/81055/vdc_100030628203.0x00005c